Isadora Fabris Laber

Ms. Isadora Fabris Laber

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2023 in Mycotoxin Research
Verified
Journal Article
Closed access
PDF file
LSLuara Medianeira de Lima Schlösser
Luara Medianeira de Lima Schlösser
CSCristina Tonial Simões
Cristina Tonial Simões
JSJanine Alves Sarturi
Janine Alves Sarturi
CSCristiane Rosa da Silva
Cristiane Rosa da Silva
Isadora Fabris LaberIsadora Fabris Laber
Isadora Fabris Laber
CMCarlos Augusto Mallmann
Carlos Augusto Mallmann

1 December 2020 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Closed access
ASALEKSANDRO S.Da Silva
ALEKSANDRO S.Da Silva
AJAntonise M. Jaguezeski
Antonise M. Jaguezeski
Isadora Fabris LaberIsadora Fabris Laber
Isadora Fabris Laber
ALAna Eucares von Laer
Ana Eucares von Laer
LLLuciane T. Lovato
Luciane T. Lovato
AMAnderson B. de Moura
Anderson B. de Moura

3 July 2023 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
CSCristina Tonial Simões
Cristina Tonial Simões
JVJuliano Kobs Vidal
Juliano Kobs Vidal
CSCristiane da Rosa da Silva
Cristiane da Rosa da Silva
JSJanine Alves Sarturi
Janine Alves Sarturi
Isadora Fabris LaberIsadora Fabris Laber
Isadora Fabris Laber
CMCarlos Augusto Mallmann
Carlos Augusto Mallmann

16 June 2025 in Food Chemistry
Verified
Journal Article
Closed access
CSCristiane Rosa da Silva
Cristiane Rosa da Silva
CSCristina Tonial Simões
Cristina Tonial Simões
Isadora Fabris LaberIsadora Fabris Laber
Isadora Fabris Laber
JSJanine Alves Sarturi
Janine Alves Sarturi
LSLuara Medianeira de Lima Schlösser
Luara Medianeira de Lima Schlösser
CMCarlos Augusto Mallmann
Carlos Augusto Mallmann

9 August 2025 in Chemosensors
Verified
Journal Article
Open access
PDF file
Isadora Fabris LaberIsadora Fabris Laber
Isadora Fabris Laber
CSCristina Tonial Simões
Cristina Tonial Simões
CSCristiane Rosa da Silva
Cristiane Rosa da Silva
LSLuara Schlosser
Luara Schlosser
JSJanine Alves Sarturi
Janine Alves Sarturi
CMCarlos Augusto Mallmann
Carlos Augusto Mallmann
Deoxynivalenol (DON) and zearalenone (ZEN) are common mycotoxins in animal feeds, and their metabolites can be detected in exposed animals. Traditional methods focus on mycotoxin detection in feed, whereas biomarker-based approaches are used for evaluating individual exposure. This study aimed to develop and validate a multi-analyte method for the detection of biomarkers of ZEN, DON, and their metabolites α-zearalanol (α-ZAL), zearalanone (ZAN), deepoxy-DON (DOM-1), and 3-acetyl-DON (3-ADON) in swine using dried blood spots (DBSs) on qualitative filter paper. Analysis was performed using high-performance liquid chromatography–tandem mass spectrometry. Blank blood samples from three male pigs were fortified with 20, 40, and 60 μg/L of each analyte. Aliquots of 40 μL were spotted onto filter paper and then extracted and analyzed. Method validation included evaluating limits of detection and quantification, linearity, matrix effects, recovery, repeatability, intermediate precision, and selectivity. All analytes were detectable in DBS. Also, ZEN, ZAN, DON, and DOM-1 met all validation criteria, with recovery values of 89.10%, 79.79%, 101.50%, and 79.50%, respectively. Both α-ZAL and 3-ADON showed lower recoveries (74.66% and 58.66%). The method was successfully validated for simultaneous analysis of ZEN, ZAN, DON, and DOM-1 in swine DBS, offering a practical and minimally invasive tool for biomonitoring mycotoxin exposure.

27 November 2023 in World Mycotoxin Journal
Verified
Journal Article
Closed access
PDF file
JSJ. Alves Sarturi
J. Alves Sarturi
CSCristina Tonial Simões
Cristina Tonial Simões
CSC. Rosa da Silva
C. Rosa da Silva
Isadora Fabris LaberIsadora Fabris Laber
Isadora Fabris Laber
LSLuara Schlosser
Luara Schlosser
CMCarlos Augusto Mallmann
Carlos Augusto Mallmann
This study aimed to develop an ex vivo model to evaluate the efficacy of antimycotoxin additives (AMAs) against aflatoxin B1 (AFB1) and fumonisin B1 (FB1) using intestinal explants of growing pigs. Four assays of two treatments with 12 replicates each (24 jejunal explants used per assay) were performed using an Ussing Chamber (UC) system: two assays to evaluate two AMAs for AFB1 and two assays to evaluate two AMAs for FB1. The difference between the two assays for both AFB1 and FB1 was the composition of the additive used. The treatments for AFB1 assays were control [Buffer solution (BS) + 1 mg/l AFB1] and AMA (BS + 1 mg/l AFB1 + 0.5% AMA 1 or 2). The treatments for FB1 assays were control (BS + 50 mg/l FB1) and AMA (BS + 50 mg/l FB1 + 0.5% AMA 3 or 4). The efficacy of the four additives was also tested in vitro. The AFB1 concentrations in the explants from AMAs 1 and 2 were lower () than in the control. AMAs 1 and 2 reduced the jejunal absorption of AFB1 by 83.4 and 72.9%, respectively. Explants from AMAs 3 and 4 had lower FB1 () concentration when compared to the respective control treatment. AMAs 3 and 4 reduced the FB1 absorption by 31.9 and 17.6%, respectively. In the in vitro test, AMAs 1 and 2 provided 98.4 and 86.3% of AFB1 adsorption, respectively, while AMA 3 and 4 provided 91.2 and 80.5% FB1 adsorption, respectively. The ex vivo model can be a useful tool in evaluating the effectiveness of antimycotoxin additives for AFB1 and FB1 in swine. However, the low FB1 uptake in jejunal explants highlights the need for the development of additional information to improve the method.